Krystal Biotech, Inc. (KRYS)
320.14
+3.56
(+1.12%)
USD |
NASDAQ |
Oct 19, 13:19
Krystal Biotech Cash from Operations (Annual) : 200.86M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 200.86M |
| December 31, 2024 | 123.42M |
| December 31, 2023 | -88.80M |
| December 31, 2022 | -100.57M |
| December 31, 2021 | -47.94M |
| Date | Value |
|---|---|
| December 31, 2020 | -26.08M |
| December 31, 2019 | -18.71M |
| December 31, 2018 | -9.445M |
| December 31, 2017 | -3.89M |
| December 31, 2016 | -1.311M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| TG Therapeutics, Inc. | -24.77M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Cytokinetics, Inc. | -510.01M |
| Exelixis, Inc. | 884.27M |
| Ionis Pharmaceuticals, Inc. | -268.58M |